SCHEMBL822744

SCHEMBL822744

Cn1c(-c2ccccc2)c(-c2ccccc2)c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
LMNA P02545 2/20 0.59
HSD17B10 Q99714 3/20 0.57
CYP2C19 P33261 1/20 0.57
HPGD P15428 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.53
KMT2A Q03164 2/20 0.53
GPR3 P46089 1/20 0.52
L3MBTL1 Q9Y468 4/20 0.51
ATM Q13315 2/20 0.51
NPC1 O15118 1/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HK1 P19367 1/20 0.48
HKDC1 Q2TB90 1/20 0.48
CYP11B2 P19099 1/20 0.46
NTRK1 P04629 1/20 0.45
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4568008 0.91 ALDH1A1 (0.51) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL7041520 0.90 HSD17B10 (0.56) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL17883125 0.90 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL17883061 0.87 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL7035424 0.87 L3MBTL1 (0.68) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL12296823 0.87 L3MBTL1 (0.50) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL10986557 0.86 KDM4E (0.54) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL17403816 0.86 NPSR1 (0.51) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL7036317 0.85 HSD17B10 (0.51) ALDH1A1LMNAHSD17B10CYP2C19HPGD
SCHEMBL28195445 0.85 ALDH1A1 (0.49) ALDH1A1LMNAHSD17B10CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215446-A1 LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-06-27 US disclosed
US-11839140-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS UDC IRELAND LIMITED (IE) 2023-12-05 US disclosed
US-11839140-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS UDC IRELAND LIMITED (IE) 2023-12-05 US disclosed
US-20230026258-A1 Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS UDC IRELAND LTD (IE) 2023-01-26 US disclosed
US-20220144869-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS UDC IRELAND LIMITED (IE) 2022-05-12 US disclosed
US-11189806-B2 Heteroleptic carbene complexes and the use thereof in organic electronics UDC IRELAND LIMITED (IE) 2021-11-30 US disclosed
EP-3647392-B1 LIGHT-EMITTING MATERIAL, COMPOUND, LONG-PERSISTENT PHOSPHOR AND LIGHT-EMITTING ELEMENT KYULUX INC (JP) 2021-09-08 EP disclosed
US-20210126207-A1 Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS UDC IRELAND LTD (IE) 2021-04-29 US disclosed
US-10916716-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS UDC IRELAND LIMITED (IE) 2021-02-09 US disclosed
US-20200373503-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2020-11-26 US disclosed
US-20110309346-A1 ORGANIC ELECTRONIC DEVICES COMPRISING A LAYER COMPRISING AT LEAST ONE METAL ORGANIC COMPOUND AND AT LEAST ONE METAL OXIDE BASF SE (DE) 2011-12-22 US disclosed
US-20110309346-A1 ORGANIC ELECTRONIC DEVICES COMPRISING A LAYER COMPRISING AT LEAST ONE METAL ORGANIC COMPOUND AND AT LEAST ONE METAL OXIDE BASF SE (DE) 2011-12-22 US disclosed
WO-2011158204-A1 ORGANIC ELECTRONIC DEVICES COMPRISING THE LAYER CONTAINING AT LEAST ONE METAL ORGANIC COMPOUND AND AT LEAST ONE METAL OXIDE BASF SE (DE) 2011-12-22 WO disclosed
US-20110253988-A1 BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS BASF SE (DE) 2011-10-20 US disclosed
US-20110253988-A1 BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS BASF SE (DE) 2011-10-20 US disclosed
WO-2011073149-A1 METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS BASF SE (DE) 2011-06-23 WO disclosed
WO-2011051404-A1 HETEROLEPTIC CARBENE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2011-05-05 WO disclosed
WO-2010079051-A1 SILYL AND HETEROATOM SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZO PHOSPHOLES AND THE APPLICATION THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2010-07-15 WO disclosed
US-7300709-B2 Organic element for electroluminescent devices EASTMAN KODAK COMPANY (US) 2007-11-27 US disclosed
US-7300709-B2 Organic element for electroluminescent devices EASTMAN KODAK COMPANY (US) 2007-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144869-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS OCIAD2, OCIAD1, CLTB ALDH1A1 3145/4885LMNA 4599/4885HSD17B10 3062/4885
US-20110253988-A1 BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS CCND1, DRD2, CCND2 ALDH1A1 502/4885LMNA 4493/4885HSD17B10 2183/4885
US-20230026258-A1 Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS OCIAD1, OCIAD2, DRD2 ALDH1A1 2588/4885LMNA 4216/4885HSD17B10 1948/4885
US-20240215446-A1 LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME TPH1, HCRTR1, HTR3D ALDH1A1 17/4885LMNA 1833/4885HSD17B10 1434/4885
US-11839140-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS OCIAD1, OCIAD2, DRD2 ALDH1A1 2588/4885LMNA 4216/4885HSD17B10 1948/4885
US-20210126207-A1 Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS OCIAD1, OCIAD2, DRD2 ALDH1A1 2588/4885LMNA 4216/4885HSD17B10 1948/4885
US-20200373503-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS OCIAD2, OCIAD1, CLTB ALDH1A1 3051/4885LMNA 4615/4885HSD17B10 3086/4885
US-11189806-B2 Heteroleptic carbene complexes and the use thereof in organic electronics OCIAD2, OCIAD1, CLTB ALDH1A1 3051/4885LMNA 4615/4885HSD17B10 3086/4885
US-10916716-B2 Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS OCIAD1, OCIAD2, DRD2 ALDH1A1 2588/4885LMNA 4216/4885HSD17B10 1948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.